OncoImmunology
Volume 12, 2023 - Issue 1
Open access
1,280
Views
0
CrossRef citations to date
0
Altmetric
Original Research
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor
Annat Raitera Felsenstein Medical Research Center, Tel Aviv University, Faculty of Medicine, Petach Tikva, IsraelCorrespondence[email protected]
https://orcid.org/0000-0001-7357-1662View further author information
Julia Lipovetskyb Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, IsraelView further author information
, Asaf Stenbaca Felsenstein Medical Research Center, Tel Aviv University, Faculty of Medicine, Petach Tikva, IsraelView further author information
, Ido Lubina Felsenstein Medical Research Center, Tel Aviv University, Faculty of Medicine, Petach Tikva, IsraelView further author information
& Rinat Yerushalmia Felsenstein Medical Research Center, Tel Aviv University, Faculty of Medicine, Petach Tikva, Israel;b Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, IsraelCorrespondence[email protected]
View further author information
View further author information
Article: 2246322
|
Received 16 May 2023, Accepted 07 Aug 2023, Published online: 14 Aug 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.